IP Library Granted Patent US 8,783,249
Granted Patent B2
US 8,783,249 · App. 13/437,840 · Granted Jul 22, 2014

Inhalation apparatus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,783,249
App. No.
13/437,840
Granted
Jul 22, 2014
Kind
B2
Abstract

An inhaler is instantly activated upon its removal from a cover or cover unit, and by rotating a cartridge component of the inhaler with respect to a mouthpiece portion, so as to create a flow pathway for ambient air and particles. The cartridge component includes a chamber, whose contents typically include dry powders or the like. Upon creation of the flow pathway, the contents of the chamber are instantly accessible for immediate inhalation by a user through the mouthpiece portion.

Claims (25)

1. An inhaler comprising:

a mouthpiece; and

a cartridge including a single chamber for storing an inhalable substance shaped to create vortices within the chamber;

wherein the mouthpiece and the cartridge are engaged and configured to be rotatable from a first position wherein the chamber is closed to a second position wherein a flow pathway is formed from the ambient environment through the chamber to the mouthpiece; and

wherein the mouthpiece includes detents having edges not allowing a movement back to the first position and wherein the inhaler is a onetime use inhaler.

2. The inhaler of claim 1 , additionally comprising a mouthpiece cover.

3. The inhaler of claim 2 , wherein the mouthpiece cover and the cartridge include cooperatingly configured structures for retaining the cover in an engagement with the cartridge, once the cover has been placed on the cartridge.

4. The inhaler of claim 1 , wherein the inhalable substance is a dry powder.

5. The inhaler of claim 4 , wherein the dry powder is a bioactive molecule encapsulated in diketopiperizine microparticles.

6. The inhaler of claim 1 , wherein the chamber further comprises at least one protrusion.

7. The inhaler of claim 1 , wherein the chamber further comprises two or more grooves.

8. The inhaler of claim 1 further including a removable cover extending over an inlet opening into the cartridge and an opening on the mouthpiece.

9. A method for inhaling a substance, the method comprising:

inhaling the substance from an inhaler comprising:

a mouthpiece; and

a cartridge including a single chamber for storing an inhalable substance shaped to create vortices within the chamber;

wherein the mouthpiece and the cartridge are engaged and rotated from a first position wherein the chamber is closed to the ambient environment to a second position wherein a flow pathway is formed from the ambient environment through the chamber to the mouthpiece; and

wherein the mouthpiece includes detents having edges not allowing a movement back to the first position and wherein the inhaler is a onetime use inhaler.

10. The method of claim 9 , additionally comprising a mouthpiece cover.

11. The method of claim 10 , wherein the mouthpiece cover and the cartridge include cooperatingly configured structures for retaining the cover in an engagement with the cartridge, once the cover has been placed on the cartridge.

12. The method of claim 9 , wherein the substance is a dry powder.

13. The method of claim 12 , wherein the dry powder is a bioactive molecule encapsulated in diketopiperizine microparticles.

14. The method of claim 9 , wherein the chamber further comprises at least one protrusion.

15. The method of claim 9 , wherein the chamber further comprises two or more grooves.

16. The method of claim 9 , wherein the inhaler further includes a removable cover extending over an inlet opening into the cartridge and an opening on the mouthpiece.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 5, 2024
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: MANNKIND CORPORATION; MANNKIND LLC
Reel/Frame 067024/0082 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2019
From: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
To: MANNKIND CORPORATION
Reel/Frame 050044/0138 →
SECURITY INTEREST Recorded Aug 13, 2019
From: MANNKIND CORPORATION; MANNKIND LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050044/0181 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2016
From: AVENTISUB LLC
To: MANNKIND CORPORATION
Reel/Frame 040588/0008 →
PATENT SECURITY AGREEMENT Recorded Sep 26, 2014
From: MANNKIND CORPORATION
To: AVENTISUB LLC
Reel/Frame 033831/0110 →
SECURITY AGREEMENT Recorded Jul 3, 2013
From: MANNKIND CORPORATION
To: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
Reel/Frame 030740/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2012
From: POOLE, TRENT; STEINER, SOLOMON S.
To: MANNKIND CORPORATION
Reel/Frame 027998/0067 →